WHO ICTRP trial
Efficacy difference between low dose rituximab and mycophenolate mofetil in…
ChiCTR2100043013 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100043013 |
|---|---|
| Public title | Efficacy difference between low dose rituximab and mycophenolate mofetil in preventing recurrence of NMOSD |
| Scientific title | Efficacy difference between low dose rituximab and mycophenolate mofetil in preventing recurrence of NMOSD |
| Primary sponsor | Shandong University Qilu Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Neuromyelitis optica spectrum diseases |
| Interventions | low dose rituximab group: low dose rituximab ;mycophenolate mofetil group:mycophenolate mofetil |
| Registration date | Feb 4, 2021 |
| Target size | low dose rituximab group:30;mycophenolate mofetil group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: